logo
Science Portal
Copyright © Médecins Sans Frontières
v2.1.5209.produseast1
About MSF Science Portal
About
Contact Us
Frequently Asked Questions (FAQs)
Privacy Policy
Terms of Use
Copyright © Médecins Sans Frontières
v2.1.5209.produseast1
Showing 1 - 5 of 5 Items
Showing 1 - 5 of 5 Items
Sort By: Relevance
  • Newest to oldest
  • Oldest to newest
  • Relevance
Journal Article
|
Commentary

Perspectives on advancing countermeasures for Filovirus disease: Report from a multi-sector meeting

Sprecher A, Cross RW, Marzi A, Martins KA, Wolfe D,  et al.
2023-08-19 • Journal of Infectious Diseases
2023-08-19 • Journal of Infectious Diseases
Although there are now approved treatments and vaccines for Ebola virus disease (EVD), the case fatality of EVD remains unacceptably high even when treated with the newly approved therap...
Journal Article
|
Commentary

Revisiting the minimum incubation period of Zaire ebolavirus

Kofman AD, Haberling DL, Mbuyi G, Martel LD, Whitesell AN,  et al.
2023-08-18 • Lancet Infectious Diseases
2023-08-18 • Lancet Infectious Diseases
Journal Article
|
Short Report

Ebola epidemic — Liberia, March–October 2014

Nyenswah TG, Fahnbulleh M, Massaquoi M, Nagbe T, Bawo L,  et al.
2014-11-14 • Morbidity and Mortality Weekly Report
2014-11-14 • Morbidity and Mortality Weekly Report
On March 21, 2014, the Guinea Ministry of Health reported the outbreak of an illness characterized by fever, severe diarrhea, vomiting and a high fatality rate (59%), leading to the firs...
Journal Article
|
Research

Artesunate + amodiaquine and artesunate + sulphadoxine-pyrimethamine for treatment of uncomplicated malaria in Democratic Republic of Congo: a clinical trial with determination of sulphadoxine and pyrimethamine-resistant haplotypes

Swarthout TD, van den Broek IVF, Kayembe G, Montgomery JM, Pota H,  et al.
2006-10-01 • Tropical Medicine and International Health
2006-10-01 • Tropical Medicine and International Health
We undertook a trial of artesunate + amodiaquine (AS + AQ) and artesunate + sulphadoxine-pyrimethamine (AS + SP) in 180 children of age 6-59 months with uncomplicated malaria in Democrat...
Journal Article
|
Research

Malaria in the Nuba Mountains of Sudan: baseline genotypic resistance and efficacy of the artesunate plus sulfadoxine-pyrimethamine and artesunate plus amodiaquine combinations

Hamour S, Melaku Y, Keus K, Wambugu J, Atkin S,  et al.
2005-07-01 • Transactions of the Royal Society of Tropical Medicine and Hygiene
2005-07-01 • Transactions of the Royal Society of Tropical Medicine and Hygiene
Both northern and southern Sudan are deploying artemisinin-based combinations against uncomplicated Plasmodium falciparum malaria (artesunate+sulfadoxine-pyrimethamine [AS+SP] in the nor...